TREE OF LIFE

Tree of Life Pharma manufactures, imports and markets over-the-counter medications, advanced medical devices, unique nutritional supplements, and health products.
The broad portfolio includes innovative products in a variety of fields. TOL products provide a solution and assistance for a wide range of indications, including: aid and treatment in cases of aphthae and mouth sores, syrup and lozenges to relieve throat irritations, sprays for eradication of lice and nits and for the prevention of lice reproduction, ear drops in the spray for the relieve of pain and inflammation, babies teething gel for easing pain in the oral gums, anemia and nutritional deficiencies, plasters and emulsions for relieving muscle and joint pain and skin problems (disinfection, burns, bites, acne, warts).
Tree of Life Pharma manufactures medical devices and cosmetics in the following core areas:

• Babies and children
• Women's products
• Nose, ear, throat, and mouth
• First aid
• Dermatology (skin)

Tree of Life Pharma has several unique series:

• Chamomilo series –Designed for children and babies.
• Dragon series - Designed for back, muscle and joint pains.
• No-Cough series - Designed to relieve throat irritations.
• Hyaluronix series - Designed to treat dry eyes and to help and relieve cases of inflammation.
• Mucoadhesive tablets innovative series - designed for a variety of indications (treatment of aphthous ulcers, oral malodor and more).

In addition to management of products under the company's brand, the company has PL (Private Label) activity that includes the production and management of unique medical devices, as a private label for a variety of leading pharma companies and healthcare providers, in Israel and around the world. In recent years, the company has expanded its PL operations in the core areas to the global market and its products are currently sold in about ~13 different countries.
The company possess a modern and versatile production facility, located at the center of Israel (Lod). The manufacturing facility produces ~1 million units per year (on average) and ~250 different products. It combines a variety of different technologies used to manufacture liquids, solids, semi-solid products, and a wide variety of additional dosage forms.

The production facility holds GMP licenses in accordance with the requirements of the Ministry of Health and comply with international standards of quality assurance (GMP, ISO 9001, ISO 13485, ISO 22716)